Baxalta

Baxalta
TypeSubsidiary
NYSE: BXLT
IndustryBiotechnology
Founded2015 (2015) (Spun off from Baxter International)
FateAcquired by Shire
Headquarters
United States Edit this on Wikidata
Key peopleLudwig N. Hantson (president and CEO)
ProductsHematology, Immunology, Pulmonology
Number of employees
16,000
ParentTakeda Pharmaceutical Company
Websitewww.baxalta.com Edit this on Wikidata

Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound') is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company.